Imaging and staging of head and neck cancer using a low pH in-111-bleomycin complex

Umezawa, 1966, New antibiotics, bleomycin A and B, J Antibiot (A), 19, 200 Umezawa, 1967, Studies on bleomycin, Cancer, 20, 891, 10.1002/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V Renault, 1973, Chelation de cations radiactifs par un polypeptide: la bleomycine, Vol. II, 195 Nieweg, 1989, 57Co-bleomycin scintigraphy for the staging of lung cancer, Cancer, 63, 1119, 10.1002/1097-0142(19890315)63:6<1119::AID-CNCR2820630613>3.0.CO;2-X Frederiksen, 1988, 57Co-bleomycin scintigraphy for the preoperative detection and staging of lung tumors, Nucl Med, 27, 79 Even-Sapir, 1994, SPECT quantitation of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancer, J Nucl Med, 35, 1129 Thakur, 1973, Some pharmacological aspects of a new radiopharmaceutical, 111In-bleomycin, Vol. II, 183 Hou, 1984, A new 111-In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice, J Surg Oncol, 25, 168, 10.1002/jso.2930250307 Gment, 1988, Indium 111-A-bleomycin—a new tracer for imaging orofacial neoplasms, J Oral Maxillofac Surg, 46, 742, 10.1016/0278-2391(88)90183-8 Hiltunen, 1990, Pharmacokinetic properties of low pH In-111-bleomycin complex, 136 Kairemo, 1990, Imaging of head and neck carcinomas with low pH 111 In-bleomycin complex, Aust NZ J Med, 20, 448 Watkinson, 1989, Technetium-99m(V) dimercaptosuccinin acid uptake in patients with head and neck squamous carcinoma: experience in imaging, J Nucl Med, 30, 174 Cummings, 1981, Assessment of cobalt-57 tagged bleomycin as a clinical aid in staging head and neck carcinoma, Laryngoscope, 91, 529, 10.1288/00005537-198104000-00006 Higashi, 1977, Gallium-67 scanning in the evaluation of therapy of malignant tumors of the head and neck, J Nucl Med, 18, 243 Teates, 1980, Gallium-67 citrate imaging in head and neck tumors: report of co-operative group, J Nucl Med, 21, 622 Goode, 1973, Radioisotope scanning for tumors of the head and neck—experience with indium-111 and phosphorus-32, Arch Otolaryngol, 97, 313, 10.1001/archotol.1973.00780010322005 Kairemo, 1990, Diagnosis of tumors of the parotid gland with anti-CEA immunoscintigraphy, Am J Roentgenol, 154, 1259, 10.2214/ajr.154.6.2110740 Kairemo, 1990, Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies, Laryngoscope, 100, 1077, 10.1288/00005537-199010000-00010 Baum, 1993, A novel Tc-99m labeled monoclonal antibody (174 H.64) for staging head and neck cancer by immuno-SPECT, Acta Oncol, 32, 747, 10.3109/02841869309096131 Soo, 1987, Radioimmuno-32#scintigraphy of squamous carcinomas of the head and neck, Head Neck Surg, 9, 349, 10.1002/hed.2890090608 Van Dongen, 1992, Radioimmunoscintigraphy of head and neck tumors using 99mTc-labeled monoclonal antibody E48 F(ab′)2, Cancer Res, 52, 2569 Schrijvers, 1993, MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck, Cancer Res, 53, 3524 De Bree, 1994, Clinical imaging of head and neck cancer with 99mTc-labeled monoclonal antibody E48 IgG or F(ab′)2, J Nucl Med, 35, 775 Snyder, 1969, Estimates of absorbed fractions for monoenergetic photo sources uniformly distributed in various organs of a heterogenous phantom: MIRD Pamphlet no. 5, J Nucl Med, 10, 7 Stabin M. MIRDOSE 3, Radiation International Dose Information Center, Institute for Science and Education, USA. Kairemo KJA, Ramsay HA, Paavonen T, et al. Dosimetric and biokinetic aspects of indium-111-bleomycin complex in head and neck cancer—implementations for radiochemotherapy. Cancer Detect Prevent, in press. Pohjonen, 1996, Registration and display of brain SPECT and MRI using external markers, Neuroradiology, 38, 108, 10.1007/BF00604791 Shanta, 1980, Combined bleomycin and radio-therapy in oral cancer, Clin Radiol, 31, 617, 10.1016/S0009-9260(80)80069-9 Fu, 1987, Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer, J Clin Oncol, 5, 1410, 10.1200/JCO.1987.5.9.1410 Vermund, 1985, Bleomycin and radiation therapy in squamous cell carcinoma of the upper aerodigestive tract: a phase III clinical trial, Int J Radiat Oncol Biol Phys, 11, 1877, 10.1016/0360-3016(85)90267-6 Eisenberger, 1992, Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck, 19, 41 Howell, 1993, On the equivalent dose for Auger electron emitters, Radiation Res, 134, 71, 10.2307/3578503 Narra, 1994, The relative biological effectiveness of 99mTc radio-pharmaceuticals, Med Phys, 21, 1921, 10.1118/1.597230 Fujimoto, 1974, Radioautoradiographic studies on the intracellular distribution of 14C-bleomycin in mouse tumor cells, Cancer Res, 34, 2969 Dorr, 1992, Bleomycin pharmacology: mechanisms of action and resistance, and clinical pharmacokinetics, 3 Hou, 1992, Distribution of 111 In-bleomycin complex in small cell lung cancer cells by autoradiography, J Surg Oncol, 49, 93, 10.1002/jso.2930490206 Kasai, 1978, Chemistry of bleomycin. XXII. Interaction of bleomycin with nucleic acids, preferential binding to guanine base and electrostatic effect of the terminal amine, J Antibiot (A), 31, 1316, 10.7164/antibiotics.31.1316 Barranco, 1973, Response of mammalian cells following treatment with bleomycin and 1,3-bis(2-chloroethyl)1-nitrosourea during plateau phase, Cancer Res, 33, 691 Barlogie, 1976, Pulse cytometric analysis of cell cycle perturbation with bleomycin in vitro, Cancer Res, 36, 1182 Hou, 1992, Chromosome aberrations of human small cell lung cancer induced by a new 111 In-bleomycin complex, J Surg Oncol, 51, 236, 10.1002/jso.2930510407 Kuwahara, 1988, Sequence-specific recognition with cleavage of DNA by metallomycin: minor groove binding and possible interaction mode, 85, 2459 Kakinuma, 1982, DNA interaction with 57Co bleomycin, Nuklearmedizin, 21, 232, 10.1055/s-0037-1620585 Sgouros, 1993, Bone marrow dosimetry for radioimmunotherapy: theoretical considerations, J Nucl Med, 34, 689